Enhanced anti-proliferative effects of combinatorial treatment of δ-tocopherol and resveratrol in human HMC-1 cells

BioFactors

Volumn 30, Issue 2, 2007, Pages 67-77

  Reiter, Elke ^a   Azzi, Angelo ^a   Zingg, Jean Marc ^a,b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b TUFTS UNIVERSITY   (United States)

^c Institute of Biochemistry and Molecular Biology   (Switzerland)

Author keywords

Akt; Mast cells; Proliferation; Resveratrol; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; BETA TOCOPHEROL; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; PROTEIN KINASE B; RESVERATROL; SERINE;

ARTICLE; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MAST CELL; MASTOCYTOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ALPHA-TOCOPHEROL; BETA-TOCOPHEROL; CELL DIVISION; CELL LINE, TUMOR; DRUG INTERACTIONS; ENZYME INHIBITORS; GAMMA-TOCOPHEROL; HUMANS; MAST CELLS; MASTOCYTOMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; STILBENES; TOCOPHEROLS;

EID: 41849145350     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520300201     Document Type: Article

References (45)

1. B.B. Aggarwal, A. Bhardwaj, R.S. Aggarwal, N.P. Seeram, S. Shishodia and Y. Takada, Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res 24 (2004), 2783-2840.
2. M.H. Aziz, M. Nihal, V.X. Fu, D.F. Jarrard and N. Ahmad, Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins, Mol Cancer Ther 5 (2006), 1335-1341.
3. L. Baolin, Y. Inami, H. Tanaka, N. Inagaki, M. Iinuma and H. Nagai, Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro, Planta Med 70 (2004), 305-309.
4. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, A. Kalra, V.V. Prabhu, J.S. Allard, G. Lopez-Lluch, K. Lewis, P.J. Pistell, S. Poosala, K.G. Becker, O. Boss, D. Gwinn, M. Wang, S. Ramaswamy, K.W. Fishbein, R.G. Spencer, E.G. Lakatta, D. Le Couteur, R.J. Shaw, P. Navas, P. Puigserver, D.K. Ingram, R. de Cabo and D.A. Sinclair, Resveratrol improves health and survival of mice on a high-calorie diet, Nature 444 (2006), 337-342.
5. D.A. Benitez, E. Pozo-Guisado, M. Clementi, E. Castellon and P.M. Fernandez-Salguero, Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway, Br J Cancer 96 (2007), 1595-1604.
6. J.H. Butterfield, D. Weiler, G. Dewald and G.J. Gleich, Establishment of an immature mast cell line from a patient with mast cell leukemia, Leuk Res 12 (1988), 345-355.
7. R. Cazzolli, L. Carpenter, T.J. Biden and C. Schmitz-Peiffer, A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate, Diabetes 50 (2001), 2210-2218.
8. S.S. Chan, H.P. Monteiro, F. Schindler, A. Stern and V.B. Junqueira, Alpha-tocopherol modulates tyrosine phosphorylation in human neutrophils by inhibition of protein kinase C activity and activation of tyrosine phosphatases, Free Radic Res 35 (2001), 843-856.
9. S. Chanvitayapongs, B. Draczynska-Lusiak and A.Y. Sun, Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells, Neuroreport 8 (1997), 1499-1502.
10. J.Q. Cheng, C.W. Lindsley, G.Z. Cheng, H. Yang and S.V. Nicosia, The Akt/PKB pathway: molecular target for cancer drug discovery, Oncogene 24 (2005), 7482-7492.
11. M.M. Corsi, W. Ponti, F. Ferrara, A. Venditti, A. Malavazos, M. Ruscica, D. Mihali, G.M. Diana, L. Paraboni and A.A. Bertelli, Nanomolar level of resveratrol (trans-3,5,4′-trihydroxystilbene) is required, but is not sufficient, to inhibit the growth of human monocytoid tumor cells through an apoptotic-like mechanism, Drugs Exp Clin Res 28 (2002), 235-242.
12. D. Delmas, B. Jannin and N. Latruffe, Resveratrol: preventing properties against vascular alterations and ageing, Mol Nutr Food Res 49 (2005), 377-395.
13. L.Q. Dong and F. Liu, PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle, Am J Physiol Endocrinol Metab 289 (2005), E187-E196.
14. T. Furitsu, T. Tsujimura, T. Tono, H. Ikeda, H. Kitayama, U. Koshimizu, H. Sugahara, J.H. Butterfield, L.K. Ashman, Y. Kanayama et al., Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product, J Clin Invest 92 (1993), 1736-1744.
15. S. Godichaud, K. Si-Tayeb, N. Auge, A. Desmouliere, C. Balabaud, B. Payrastre, A. Negre-Salvayre and J. Rosenbaum, The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts, Int J Biochem Cell Biol 38 (2006), 629-637.
16. D.M. Goldberg, J. Yan and G.J. Soleas, Absorption of three wine-related polyphenols in three different matrices by healthy subjects, Clin Biochem 36 (2003), 79-87.
17. U.G. Haider, T.U. Roos, M.I. Kontaridis, B.G. Neel, D. Sorescu, K.K. Griendling, A.M. Vollmar and V.M. Dirsch, Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2, Mol Pharmacol 68 (2005), 41-48.
18. B. Halliwell, J. Rafter and A. Jenner, Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr 81 (2005), 268S-276S.
19. D.M. Harris, E. Besselink, S.M. Henning, V.L. Go and D. Heber, Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells, Exp Biol Med (Maywood) 230 (2005), 558-568.
20. A. Hosomi, M. Arita, Y. Sato, C. Kiyose, T. Ueda, O. Igarashi, H. Arai and K. Inoue, Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs, FEBS Lett 409 (1997), 105-108.
21. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W.W. Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon and J.M. Pezzuto, Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes, Science 275 (1997), 218-220.
22. P. Kempna, E. Reiter, M. Arock, A. Azzi and J.M. Zingg, Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway, J Biol Chem 279 (2004), 50700-50709.
23. S. Khanna, M. Venojarvi, S. Roy, N. Sharma, P. Trikha, D. Bagchi, M. Bagchi and C.K. Sen, Dermal wound healing properties of redox-active grape seed proanthocyanidins, Free Radic Biol Med 33 (2002), 1089-1096.
24. S.K. Lee, K.A. Nam, Y.H. Hoe, H.Y. Min, E.Y. Kim, H. Ko, S. Song, T. Lee and S. Kim, Synthesis and evaluation of cytotoxicity of stilbene analogues, Arch Pharm Res 26 (2003), 253-257.
25. H.Y. Lin, L. Lansing, J.M. Merillon, F.B. Davis, H.Y. Tang, A. Shih, X. Vitrac, S. Krisa, T. Keating, H.J. Cao, J. Bergh, S. Quackenbush and P.J. Davis, Integrin alphaVbeta3 contains a receptor site for resveratrol, Faseb J 20 (2006), 1742-1744.
26. B.D. Manning and L.C. Cantley, AKT/PKB Signaling: Navigating Downstream, Cell 129 (2007), 1261-1274.
27. B.S. McIntyre, K.P. Briski, M.A. Tirmenstein, M.W. Fariss, A. Gapor and P.W. Sylvester, Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells, Lipids 35 (2000), 171-180.
28. A. Munteanu, M. Taddei, I. Tamburini, E. Bergamini, A. Azzi and J.M. Zingg, Antagonistic effects of oxLDL and alpha -tocopherol on CD36 scavenger receptor expression in monocytes; involvement of PKB and PPARgamma, J Biol Chem 281 (2006), 6489-6497.
29. J. Neuzil, L.F. Dong, X.F. Wang and J.M. Zingg, Tocopherol-associated protein-1 accelerates apoptosis induced by alpha-tocopheryl succinate in mesothelioma cells, Biochem Biophys Res Commun 343 (2006), 1113-1117.
30. J. Ni, X. Wen, J. Yao, H.C. Chang, Y. Yin, M. Zhang, S. Xie, M. Chen, B. Simons, P. Chang, A. di Sant'Agnese, E.M. Messing and S. Yeh, Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway, Cancer Res 65 (2005), 9807-9816.
31. B. Olas and B. Wachowicz, Resveratrol, a phenolic antioxidant with effects on blood platelet functions, Platelets 16 (2005), 251-260.
32. M. Pastori, H. Pfander, D. Boscoboinik and A. Azzi, Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells, Biochem Biophys Res Commun 250 (1998), 582-585.
33. S. Pervaiz, Resveratrol: from grapevines to mammalian biology, Faseb J 17 (2003), 1975-1985.
34. T.M. Poolman, L.L. Ng, P.B. Farmer and M.M. Manson, Inhibition of the respiratory burst by resveratrol in human monocytes: correlation with inhibition of PI3K signaling, Free Radic Biol Med 39 (2005), 118-132.
35. E. Pozo-Guisado, M.J. Lorenzo-Benayas and P.M. Fernandez-Salguero, Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation, Int J Cancer 109 (2004), 167-173.
36. E. Reboul, A. Klein, F. Bietrix, B. Gleize, C. Malezet-Desmoulins, M. Schneider, A. Margotat, L. Lagrost, X. Collet and P. Borel, Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte, J Biol Chem 281 (2006), 4739-4745.
37. S. Sale, R.D. Verschoyle, D. Boocock, D.J. Jones, N. Wilsher, K.C. Ruparelia, G.A. Potter, P.B. Farmer, W.P. Steward and A.J. Gescher, Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene, Br J Cancer 90 (2004), 736-744.
38. M.T. Schroeder, E.M. Becker and L.H. Skibsted, Molecular mechanism of antioxidant synergism of tocotrienols and carotenoids in palm oil, J Agric Food Chem 54 (2006), 3445-3453.
39. E. Sexton, C. Van Themsche, K. LeBlanc, S. Parent, P. Lemoine and E. Asselin, Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells, Mol Cancer 5 (2006), 45.
40. P. Signorelli and R. Ghidoni, Resveratrol as an anticancer nutrient: molecular basis, open questions and promises, J Nutr Biochem 16 (2005), 449-466.
41. C.S. Watson, R.A. Alyea, Y.J. Jeng and M.Y. Kochukov, Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues, Mol Cell Endocrinol 274 (2007), 1-7.
42. E. Wenzel and V. Somoza, Metabolism and bioavailability of trans-resveratrol, Mol Nutr Food Res 49 (2005), 472-481.
43. Y. Zhang, J. Ni, E.M. Messing, E. Chang, C.R. Yang and S. Yeh, Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells, Proc Natl Acad Sci USA 99 (2002), 7408-7413.
44. J.M. Zingg, Vitamin E and mast cells, Vitam Horm 76 (2007), 393-418.
45. J.M. Zingg and A. Azzi, Non-antioxidant activities of vitamin E, Curr Med Chem 11 (2004), 1113-1133.